OAM
EXAS

Oppenheimer Asset Management’s Exact Sciences EXAS Stock Holding History

Oppenheimer Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,149
Closed -$1.13M – 1132
2025
Q4 		$1.13M Sell
11,149
-16,591
-60% -$1.33M 0.01% 648
2025
Q3 		$1.52M Buy
27,740
+8,191
+42% +$409K 0.02% 650
2025
Q2 		$1.04M Buy
19,549
+1,402
+8% +$71.2K 0.01% 738
2025
Q1 		$786K Buy
18,147
+1,369
+8% +$69.3K 0.01% 773
2024
Q4 		$943K Buy
16,778
+2,030
+14% +$126K 0.01% 730
2024
Q3 		$1M Sell
14,748
-84
-0.6% -$4.74K 0.01% 720
2024
Q2 		$627K Buy
14,832
+6,427
+76% +$354K 0.01% 811
2024
Q1 		$580K Buy
8,405
+1,307
+18% +$82.7K 0.01% 802
2023
Q4 		$525K Buy
7,098
+2,295
+48% +$150K 0.01% 852
2023
Q3 		$328K Sell
4,803
-1,519
-24% -$129K 0.01% 949
2023
Q2 		$594K Sell
6,322
-2,648
-30% -$207K 0.01% 818
2023
Q1 		$608K Sell
8,970
-1,076
-11% -$69.2K 0.01% 799
2022
Q4 		$497K Sell
10,046
-4,864
-33% -$199K 0.01% 863
2022
Q3 		$484K Sell
14,910
-596
-4% -$24.6K 0.01% 843
2022
Q2 		$611K Sell
15,506
-7,017
-31% -$375K 0.01% 805
2022
Q1 		$1.57M Sell
22,523
-1,106
-5% -$80.8K 0.02% 604
2021
Q4 		$1.84M Buy
23,629
+471
+2% +$41.6K 0.02% 581
2021
Q3 		$2.21M Buy
23,158
+5,528
+31% +$584K 0.03% 511
2021
Q2 		$2.19M Buy
17,630
+2,687
+18% +$321K 0.03% 497
2021
Q1 		$1.97M Buy
14,943
+2,215
+17% +$303K 0.03% 516
2020
Q4 		$1.69M Buy
12,728
+3,592
+39% +$434K 0.03% 528
2020
Q3 		$932K Buy
9,136
+2,066
+29% +$178K 0.02% 639
2020
Q2 		$614K Buy
7,070
+6,182
+696% +$494K 0.01% 740
2020
Q1 		$52K Sell
888
-2,533
-74% -$206K ﹤0.01% 1252
2019
Q4 		$316K Buy
3,421
+1,895
+124% +$167K 0.01% 949
2019
Q3 		$138K Buy
1,526
+776
+103% +$88.4K ﹤0.01% 1121
2019
Q2 		$88K Buy
750
+679
+956% +$68.4K ﹤0.01% 1254
2019
Q1 		$6K Sell
71
-30
-30% -$2.55K ﹤0.01% 1515
2018
Q4 		$6K Buy
+101
New +$6.93K ﹤0.01% 1540
2017
Q4 		– Sell
-3,177
Closed -$150K – 1198
2017
Q3 		$150K Buy
3,177
+3,072
+2,926% +$124K ﹤0.01% 1113
2017
Q2 		$4K Buy
+105
New +$3.24K ﹤0.01% 1572

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Oppenheimer Asset Management's EXAS Position: Q1 2026 in Review

Oppenheimer Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,149 shares — an estimated $1.13M sold.

Oppenheimer Asset Management first reported a position in EXAS in Q2 2017 and held it in 31 quarters. The position peaked at $2.21M in Q3 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Oppenheimer Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Oppenheimer Asset Management sold 11,149 Exact Sciences shares in Q1 2026, an estimated $1.13M.
  • Oppenheimer Asset Management first reported a position in Exact Sciences in Q2 2017 and held it in 31 quarters.
  • Oppenheimer Asset Management's Exact Sciences position peaked at $2.21M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.